Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Browse
Podcasts
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Browse
Podcasts
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 60, Issue 5
No benefit from mirtazapine for treating agitation in dementia
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
DTB select
No benefit from mirtazapine for treating agitation in dementia
Online download statistics by month:
Online download statistics by month: March 2022 to February 2024
Abstract
Full
Pdf
Mar 2022
914
43
24
Apr 2022
640
15
15
May 2022
1234
23
24
Jun 2022
320
9
3
Jul 2022
283
10
3
Aug 2022
368
15
5
Sep 2022
580
21
23
Oct 2022
406
20
12
Nov 2022
93
5
0
Dec 2022
85
1
0
Jan 2023
93
2
2
Feb 2023
142
0
0
Mar 2023
73
2
0
Apr 2023
111
3
0
May 2023
53
2
3
Jun 2023
48
0
0
Jul 2023
34
0
0
Aug 2023
55
1
1
Sep 2023
122
1
1
Oct 2023
40
6
3
Nov 2023
60
2
2
Dec 2023
33
1
1
Jan 2024
47
1
1
Feb 2024
55
2
2
Total
5889
185
125
Read the full text or download the PDF:
Subscribe (£100)
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?